Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Lintuzumab

😃Good
Catalog No. T9901A-065Cas No. 166089-32-3
Alias SGN-33, SGN33, HuM-195, HuM195

Lintuzumab (HuM-195) is a non-coupled humanized mouse monoclonal antibody directed against the cell-surface myelomonocyte differentiation antigen, CD33, with anti-leukemic activity that reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells.Lintuzumab has antitumor activity and induces cell death directly via CDC or ADCC. Lintuzumab has anti-tumor activity and induces cell death directly via CDC or ADCC.

Lintuzumab

Lintuzumab

😃Good
Catalog No. T9901A-065Alias SGN-33, SGN33, HuM-195, HuM195Cas No. 166089-32-3
Lintuzumab (HuM-195) is a non-coupled humanized mouse monoclonal antibody directed against the cell-surface myelomonocyte differentiation antigen, CD33, with anti-leukemic activity that reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells.Lintuzumab has antitumor activity and induces cell death directly via CDC or ADCC. Lintuzumab has anti-tumor activity and induces cell death directly via CDC or ADCC.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$163In StockIn Stock
5 mg$463In StockIn Stock
10 mg$673-In Stock
25 mg$987-In Stock
50 mg$1,390-In Stock
100 mg$1,880-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.1% (SDS-PAGE); 98.2% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Lintuzumab (HuM-195) is a non-coupled humanized mouse monoclonal antibody directed against the cell-surface myelomonocyte differentiation antigen, CD33, with anti-leukemic activity that reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells.Lintuzumab has antitumor activity and induces cell death directly via CDC or ADCC. Lintuzumab has anti-tumor activity and induces cell death directly via CDC or ADCC.
SynonymsSGN-33, SGN33, HuM-195, HuM195
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetSiglec-3/CD33
Chemical Properties
Molecular Weight145.23 kDa
Cas No.166089-32-3
Relative Density.no data available
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Lintuzumab | purchase Lintuzumab | Lintuzumab cost | order Lintuzumab | Lintuzumab molecular weight